Internal Medicine, Hepatology · Pasadena, CA
NPI
1881654226
Since 2006
Specialty
Internal Medicine, Hepatology
Code 207RI0008X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
301 S Fair Oaks Ave Ste 305
Pasadena, CA, 91105
Phone (626) 440-7325
Groups this clinician bills Medicare through
Medicare paid, 2024
$131K
1,456 services
Medicare patients, 2024
694
Average age 71
Drug cost, 2024
$4.6M
5,871 prescriptions
Company payments, 2025
$149K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward A Mena was code 99214 (office e&m - established), 561 times for 416 patients. In total Edward A Mena billed 1,456 services in 10 codes, and Medicare paid $131K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 561 | 416 | $103.94 | $58K |
| 76981 Ultrasound - Nonspecific | Office | 371 | 356 | $81.04 | $30K |
| 99213 Office E&M - Established | Office | 314 | 293 | $62.36 | $20K |
| 99204 Office E&M - New | Office | 106 | 106 | $132.80 | $14K |
| 99203 Office E&M - New | Office | 57 | 57 | $78.57 | $4,479 |
| 99215 Office E&M - Established | Office | 24 | 20 | $151.03 | $3,625 |
| 99442 Telephone Services | Office | 20 | 18 | $48.75 | $975 |
By year: 2022 $99K for 1,300 services; 2023 $106K for 1,259 services; 2024 $131K for 1,456 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward A Mena prescribed most often to Medicare patients was Ursodiol, with 796 prescriptions and refills. In total Edward A Mena wrote 5,871 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ursodiol Generic | 796 | 1,352 | 175 | $115K |
| Furosemide Generic | 525 | 829 | 112 | $1,605 |
| Spironolactone Generic | 508 | 772 | 107 | $4,361 |
| Xifaxan Rifaximin | 410 | 422 | 60 | $1.2M |
| Vemlidy Tenofovir Alafenamide | 342 | 378 | 41 | $530K |
| Azathioprine Generic | 225 | 486 | 48 | $6,225 |
| Lactulose Generic | 224 | 326 | 72 | $10K |
| Prednisone Generic | 206 | 298 | 34 | $735 |
| Pantoprazole Sodium Generic | 169 | 301 | 39 | $1,193 |
| Fenofibrate Fenofibrate Nanocrystallized | 162 | 305 | 35 | $3,527 |
| Entecavir Generic | 152 | 260 | 32 | $19K |
| Folic Acid Generic | 128 | 244 | 29 | $738 |
| Rosuvastatin Calcium Generic | 106 | 238 | 30 | $1,765 |
| Carvedilol Generic | 101 | 154 | 29 | $313 |
| Tacrolimus Generic | 95 | 149 | 14 | $10K |
Brand drugs: - claims; generic drugs: 4,616 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward A Mena $149K ($146K in general payments such as food, travel and fees and $2,311 for research) from 21 companies. The largest payer was Madrigal Pharmaceuticals with $53K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 95 | $53K |
| Gilead Sciences, Inc. GILD | 43 | $35K |
| Lilly USA, LLC LLY | 38 | $24K |
| Novo Nordisk Inc NVO | 10 | $17K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 13 | $11K |
| Abbvie Inc. ABBV | 24 | $4,665 |
| Eli Lilly and Company LLY | 2 | $2,311 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 14 | $172 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $149 |
| Histosonics, Inc. | 1 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.